Niva Bupa Health (NIVABUPA) | Stock Overview & Key Data
Niva Bupa Health Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹109.34 on December 2, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Niva Bupa Health
NIVABUPA
|
149.05B Mid-cap | 2.29% | 4.46% | 16.39% | 11.36% | 11.07% | 3.13% | 13.43% | 13.43% | 13.43% | 13.43% | 13.43% |
|
Life Insurance
LICI
|
5.21T Large-cap | 2.58% | 1.53% | 4.38% | -5.31% | -4.85% | -14.85% | 32.13% | -3.32% | -3.32% | -3.32% | -3.32% |
|
SBI Life Insurance
SBILIFE
|
1.83T Large-cap | -0.28% | -5.63% | -7.84% | -13.53% | -13.77% | -2.80% | 33.14% | 73.63% | 144.85% | 144.85% | 144.85% |
|
Religare Enterprises
RELIGARE
|
73.46B Mid-cap | 7.12% | 8.45% | 8.95% | 2.70% | -2.90% | 2.69% | 38.66% | 85.48% | -12.67% | -48.00% | -52.46% |
|
HDFC Life Insurance
HDFCLIFE
|
1.29T Large-cap | 2.95% | -4.52% | -7.16% | -24.78% | -22.52% | -26.23% | -8.89% | -21.69% | 61.16% | 61.16% | 61.16% |
|
ICICI Prudential
ICICIPRULI
|
775.63B Large-cap | 2.26% | -9.23% | -16.74% | -25.03% | -27.90% | -25.63% | -12.36% | -19.28% | 50.89% | 50.89% | 50.89% |
Ownership & Short Interest
Calculate Your Niva Bupa Health Investment Returns
Long-Term Investment Performance Analysis
Niva Bupa Health stock price in Nov 2024 was ₹74.02, A ₹1,000.00 lump sum investment in Niva Bupa Health made 1 years ago would be worth approximately ₹1,126.59 today, representing a positive return of 12.66%. This translates to an annualized return (CAGR) of 7.78%.
1 Year 7 Months Investment Scenario (Nov 2024 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is NIVABUPA's 52-week high and low?
- In the last 52 weeks, Niva Bupa Health reached a high of ₹92.90 (on July 17, 2025) and a low of ₹67.50 (on March 24, 2026).
- What is the market cap and P/E ratio for NIVABUPA?
- Curious about Niva Bupa Health's size and valuation? Its market capitalization stands at 149.05B. When it comes to valuation, the P/E ratio (trailing twelve months) is 154.02, and the forward P/E (looking ahead) is 30.81.
- Does NIVABUPA pay dividends? If so, what's the yield?
- As for dividends, Niva Bupa Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Niva Bupa Health's main competitors or similar companies to consider before investing?
When looking at Niva Bupa Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Life Insurance
LICI5.21T Financial Services Insurance - Life -14.85% 32.13% SBI Life Insurance
SBILIFE1.83T Financial Services Insurance - Life -2.80% 33.14% Religare Enterprises
RELIGARE73.46B Financial Services Insurance - Life 2.69% 38.66% HDFC Life Insurance
HDFCLIFE1.29T Financial Services Insurance - Life -26.23% -8.89% ICICI Prudential
ICICIPRULI775.63B Financial Services Insurance - Life -25.63% -12.36% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Niva Bupa Health Insurance Company Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Niva Bupa Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 7.96%, the Debt to Equity ratio from the most recent quarter is 7.30, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for NIVABUPA?
- Looking at Niva Bupa Health's growth, its revenue over the trailing twelve months (TTM) was INR80B. Compared to the same quarter last year (YoY), quarterly revenue grew by 65.80%, and quarterly earnings saw a YoY growth of 167.30%.
- How much of NIVABUPA stock is held by insiders and institutions?
- Wondering who owns Niva Bupa Health stock? Company insiders (like executives and directors) hold about 76.92% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 14.60%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.